Interacting Drugs |
Drospirenone and estradiol vs P-glycoprotein/ABCB1 Inducers |
Security Level |
|
Mechanism |
P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.). |
Management |
Monitor therapy |
Drospirenone and estradiol vs P-glycoprotein/ABCB1 Inducers
Post Review about Drospirenone and estradiol vs P-glycoprotein/ABCB1 Inducers Click here to cancel reply.
Other Interactions of P-glycoprotein/ABCB1 Inducers
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.